Development of an ELISA to detect the secreted prostate cancer biomarker AGR2 in voided urine.
about
A highly sensitive targeted mass spectrometric assay for quantification of AGR2 protein in human urine and serumPersonalized medicine using DNA biomarkers: a reviewA multiplex assay to measure RNA transcripts of prostate cancer in urine.High expression of AGR2 in lung cancer is predictive of poor survival.The metastasis-inducing protein AGR2 is O-glycosylated upon secretion from mammary epithelial cells.Prostate cancer cell phenotypes based on AGR2 and CD10 expressionBladder cancer cells secrete while normal bladder cells express but do not secrete AGR2.Cancer-secreted AGR2 induces programmed cell death in normal cells.Novel methodologies in analysis of small molecule biomarkers and living cells.Recent progress in urinary proteome analysis for prostate cancer diagnosis and management.Identification and prognostic value of anterior gradient protein 2 expression in breast cancer based on tissue microarray.Emerging trends in the evaluation and management of small cell prostate cancer: a clinical and molecular perspective.N-acetyl-L-aspartyl-L-glutamate peptidase-like 2 is overexpressed in cancer and promotes a pro-migratory and pro-metastatic phenotype.Processing of voided urine for prostate cancer RNA biomarker analysis.An efficient method for native protein purification in the selected range from prostate cancer tissue digests.Single Domain Antibodies as New Biomarker Detectors.Multiplexed targeted mass spectrometry assays for prostate cancer-associated urinary proteins.Identification, characterization and application of a new peptide against anterior gradient homolog 2 (AGR2).
P2860
Q24307894-74C623C7-1863-4D88-8294-34DEE1F9DF38Q27022319-0D2BF6C3-DDBB-4DD7-9AB8-312E78547C93Q34429720-17940226-B6F5-4C7D-A82D-F43F207D3541Q36130894-3F92593C-E180-4896-8C97-B3613970F414Q36621607-BBAB7A38-4DF7-41FD-B56B-092A0D763DB3Q36800218-F7C05F16-8945-46CC-9BAD-1084E792081CQ37085875-6BACFE1E-B3DD-4B78-B8BA-52FFB1101FBBQ37580245-EDC1BF77-C5E8-4DFF-9611-3FE3FB753FD5Q38239586-5903B8C3-69F1-4A7C-97FB-FA84021662C6Q38613772-EBDA56E1-420E-4B4D-9993-E336E4084F15Q38697199-02F2F8B9-8794-4134-9BC7-2922C0194A79Q38930155-59541A22-CC7A-47A4-B3B3-9D9BE7BE12AFQ39062377-D997C61C-EAC7-4FB9-9D3C-27D353E3DD98Q40308110-A32AE315-9A48-4BE2-AAF8-3AF2454CC64AQ41824347-92BA1EB8-616C-4AA4-811A-541F54090461Q47099886-58DF595B-29E0-4474-B765-414D5A910BAFQ47136739-F07CF8A5-06E4-4268-A38B-FEB573B2C9E9Q55233846-38D35787-6918-4BB1-8135-5F4F2D959888
P2860
Development of an ELISA to detect the secreted prostate cancer biomarker AGR2 in voided urine.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
Development of an ELISA to det ...... iomarker AGR2 in voided urine.
@en
Development of an ELISA to det ...... iomarker AGR2 in voided urine.
@nl
type
label
Development of an ELISA to det ...... iomarker AGR2 in voided urine.
@en
Development of an ELISA to det ...... iomarker AGR2 in voided urine.
@nl
prefLabel
Development of an ELISA to det ...... iomarker AGR2 in voided urine.
@en
Development of an ELISA to det ...... iomarker AGR2 in voided urine.
@nl
P2093
P2860
P356
P1433
P1476
Development of an ELISA to det ...... iomarker AGR2 in voided urine.
@en
P2093
Alvin Y Liu
Elizabeth A Wayner
Lawrence D True
Melissa E Ho
Michelle A Loprieno
Rumana Ahmad
Sue-Ing Quek
William J Ellis
P2860
P304
P356
10.1002/PROS.21508
P577
2011-11-09T00:00:00Z